These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7022966)

  • 61. Immunogenetic aspects of the relationship between HLA-DR and the MB and MT system.
    Duquesnoy RJ
    Transplant Proc; 1981 Dec; 13(4):1804-7. PubMed ID: 6977217
    [No Abstract]   [Full Text] [Related]  

  • 62. Survival of heart allografts in nonimmunosuppressed murine recipients by pretreatment of the donor tissue with anti-Ia antibodies.
    Faustman D; Kraus P; Lacy PE; Finke EH; Davie JM
    Transplantation; 1982 Nov; 34(5):302-5. PubMed ID: 6961607
    [No Abstract]   [Full Text] [Related]  

  • 63. B cell responses to allograft--more common than we thought?
    Clatworthy MR
    Am J Transplant; 2013 Jul; 13(7):1629-30. PubMed ID: 23802722
    [No Abstract]   [Full Text] [Related]  

  • 64. Evidence that protective Fc-receptor-blocking antibodies in renal transplantation are alloantibodies not autoantibodies.
    MacLeod AM; Mason RJ; Power DA; Mather AJ; Edward N; Stewart KN; Shewan WG; Urbaniak S; Catto GR
    Transplantation; 1985 May; 39(5):520-3. PubMed ID: 3887692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary multicenter analysis of HLA-DRW6 effect.
    Opelz G
    Transplant Proc; 1984 Oct; 16(5):1167-9. PubMed ID: 6385366
    [No Abstract]   [Full Text] [Related]  

  • 66. Successful renal transplantation despite warm B cell antibodies.
    Deierhoi MH; Ting A; Morris PJ
    Transplantation; 1983 Aug; 36(2):207-9. PubMed ID: 6349047
    [No Abstract]   [Full Text] [Related]  

  • 67. B cell dysfunction in renal allograft recipients.
    Juskowa J; Wasik M; Nowaczyk M; Górski A
    Transplant Proc; 1987 Oct; 19(5):4300-1. PubMed ID: 3314032
    [No Abstract]   [Full Text] [Related]  

  • 68. Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation.
    Klintmalm G; Iwatsuki S; Kano T; Iwaki Y; Terasaki PI; Schröter G; Koep L; Weil R; Starzl TE
    Transplant Proc; 1981 Mar; 13(1 Pt 1):537-8. PubMed ID: 7022890
    [No Abstract]   [Full Text] [Related]  

  • 69. Improved HLA-DR typing of dialysis patients using monoclonal antibodies.
    Cicciarelli JC; Ayoub G; Terasaki PI; Billing R
    Transplantation; 1982 May; 33(5):558-60. PubMed ID: 7046167
    [No Abstract]   [Full Text] [Related]  

  • 70. Correlation between high-molecular-weight Fc gamma-receptor-blocking factors in serum and renal allograft survival.
    Forwell MA; Cocker JE; Peel MG; Tsakiris DJ; Briggs JD; Junor BJ; MacSween RN; Sandilands GP
    Transplantation; 1987 Aug; 44(2):227-33. PubMed ID: 2957829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Examination of sera from pregnant women for the presence of anti-HLA-DRw cytotoxins (author's transl)].
    Májský A
    Cas Lek Cesk; 1980 Jul; 119(27-28):764-7. PubMed ID: 6933017
    [No Abstract]   [Full Text] [Related]  

  • 72. Transplantation: Alloantibodies in simultaneous liver-kidney transplantation.
    Singer AL; Segev DL
    Nat Rev Nephrol; 2013 Jul; 9(7):373-4. PubMed ID: 23649019
    [No Abstract]   [Full Text] [Related]  

  • 73. Anti-B lymphocytotoxic antibodies and renal transplant outcome.
    Huang CC; Lai MK; Kao S; Leu ML; Chu SH; Hsu KT
    Changgeng Yi Xue Za Zhi; 1986 Dec; 9(4):232-7. PubMed ID: 3331572
    [No Abstract]   [Full Text] [Related]  

  • 74. Panel Reactive Antibody test (PRA) in renal transplantation.
    Hajeer AH
    Saudi J Kidney Dis Transpl; 2006 Mar; 17(1):1-4. PubMed ID: 17297529
    [No Abstract]   [Full Text] [Related]  

  • 75. International cell exchange.
    Bernoco D; Perdue S; Terasaki PI; Loon J; Park MS
    Transplant Proc; 1978 Dec; 10(4):717-20. PubMed ID: 83703
    [No Abstract]   [Full Text] [Related]  

  • 76. The fetus as an allograft: partial definition of the target antigens.
    Power DA; Cunningham C; Catto GR
    Scott Med J; 1986 Apr; 31(2):123-4. PubMed ID: 3738475
    [No Abstract]   [Full Text] [Related]  

  • 77. The Leiden B cell workshop May 5-8 1976.
    van Rood JJ
    Tissue Antigens; 1976 Nov; 8(5):329-44. PubMed ID: 797052
    [No Abstract]   [Full Text] [Related]  

  • 78. Not so Marginal...the Unexpected Role of Marginal Zone B Cells in Alloantibody Formation.
    Steines L
    Transplantation; 2024 Jun; 108(6):1277-1278. PubMed ID: 38514470
    [No Abstract]   [Full Text] [Related]  

  • 79. Summary report on the second New World B-cell workshop.
    Thompson JS; Braun WE; Carpenter CB; Dossetor JB; Dupont B; Falk JA; Ferrone S; Johnson AH; Shaw JF; Singal DP; Terasaki TI; Troup GM; Walford RL
    Tissue Antigens; 1976 Nov; 8(5):355-7. PubMed ID: 65026
    [No Abstract]   [Full Text] [Related]  

  • 80. Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients.
    Deierhoi MH; Radvany RM; Wolf JS
    Transplant Proc; 1981 Mar; 13(1 Pt 2):942-4. PubMed ID: 7022966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.